Alzheimer’s disease: analysis of a mathematical model incorporating the role of prions

We introduce a mathematical model of the in vivo progression of Alzheimer’s disease with focus on the role of prions in memory impairment. Our model consists of differential equations that describe the dynamic formation of $$\upbeta $$β-amyloid plaques based on the concentrations of A$$\upbeta $$β oligomers, PrPC proteins, and the A$$\upbeta $$β-$$\times $$×-PrPCcomplex, which are hypothesized to be responsible for synaptic toxicity. We prove the well-posedness of the model and provided stability results for its unique equilibrium, when the polymerization rate of $$\upbeta $$β-amyloid is constant and also when it is described by a power law.

[1]  Dietmar Oelz,et al.  Size distribution dependence of prion aggregates infectivity. , 2009, Mathematical biosciences.

[2]  S. Lehmann.  [The prion protein]. , 2002, Journal de la Societe de biologie.

[3]  S. Strittmatter,et al.  Cellular Prion Protein Mediates the Toxicity of-Amyloid Oligomers Implications for Alzheimer Disease , 2009 .

[4]  R. Carp,et al.  Scrapie-infected spleens: analysis of infectivity, scrapie-associated fibrils, and protease-resistant proteins. , 1991, The Journal of infectious diseases.

[5]  P. Laurençot,et al.  Well-posedness for a model of prion proliferation dynamics , 2007 .

[6]  J. P. Lasalle.  The stability of dynamical systems , 1976 .

[7]  D. Walsh,et al.  Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. , 1997, The Journal of biological chemistry.

[8]  T. Goudon,et al.  On solutions of the Lifshitz-Slyozov model , 2000 .

[9]  B Urbanc,et al.  Dynamics of plaque formation in Alzheimer's disease. , 1999, Biophysical journal.

[10]  F. Checler,et al.  Regulation of βAPP and PrPc Cleavage by α-Secretase: Mechanistic and Therapeutic Perspectives , 2008 .

[11]  Laurent Pujo-Menjouet,et al.  A mathematical analysis of the dynamics of prion proliferation. , 2006, Journal of theoretical biology.

[12]  M. Rowan,et al.  Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites , 2011, Nature communications.

[13]  W. Surewicz,et al.  Interaction between Human Prion Protein and Amyloid-β (Aβ) Oligomers , 2010, The Journal of Biological Chemistry.

[14]  D. Selkoe,et al.  Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior , 2008, Behavioural Brain Research.

[15]  1 The GloBAl eCoNomiC impACT oF demeNTiA Alzheimer ’ s diseAse internAtionAl World Alzheimer report 2010 the GlobAl economic impAct of dementiA , 2022 .

[16]  S. Lindquist,et al.  The cellular prion protein mediates neurotoxic signalling of β‐sheet‐rich conformers independent of prion replication , 2011, The EMBO journal.

[17]  G. Zamponi.  Faculty Opinions recommendation of Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. , 2009 .

[18]  W. Zou,et al.  Insoluble cellular prion protein and its association with prion and Alzheimer diseases , 2011, Prion.

[19]  H. Rezaei,et al.  An Efficient Kinetic Model for Assemblies of Amyloid Fibrils and Its Application to Polyglutamine Aggregation , 2012, PloS one.

[20]  W. Surewicz,et al.  Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role OF N-terminal residues. , 2010, The Journal of biological chemistry.

[21]  S. Strittmatter,et al.  Memory Impairment in Transgenic Alzheimer Mice Requires Cellular Prion Protein , 2010, The Journal of Neuroscience.

[22]  S. Gallion.  Modeling Amyloid-Beta as Homogeneous Dodecamers and in Complex with Cellular Prion Protein , 2012, PloS one.

[23]  Julie Harris,et al.  Reversing EphB2 depletion rescues cognitive functions in Alzheimer model , 2011, Nature.

[24]  Lawrence M. Wein,et al.  A mathematical model of the impact of novel treatments on the Aβ burden in the Alzheimer’s brain, CSF and plasma , 2015, Bulletin of mathematical biology.

[25]  Stéphanie Portet,et al.  An in vivo intermediate filament assembly model. , 2008, Mathematical biosciences and engineering : MBE.

[26]  George B. Benedek,et al.  Kinetic theory of fibrillogenesis of amyloid β-protein , 1997 .

[27]  M. Prince,et al.  World Alzheimer Report 2013 , 2014 .

[28]  John W. Gilbert,et al.  Cellular Prion Protein Mediates Impairment of Synaptic Plasticity by Amyloid-β Oligomers , 2009, Nature.

[29]  Marie-Claude Potier,et al.  Classification and basic pathology of Alzheimer disease , 2009, Acta Neuropathologica.

[30]  D. Kirschner,et al.  Kinetic theory of fibrillogenesis of amyloid beta-protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Pierre Gabriel,et al.  The shape of the polymerization rate in the prion equation , 2010, Math. Comput. Model..

[32]  Yves Achdou,et al.  A qualitative model for aggregation and diffusion of $$\beta $$-amyloid in Alzheimer’s disease , 2013, Journal of mathematical biology.

[33]  V. Calvez,et al.  Prion dynamics with size dependency–strain phenomena , 2010, Journal of biological dynamics.

[34]  L. Serpell,et al.  Alzheimer's amyloid fibrils: structure and assembly. , 2000, Biochimica et biophysica acta.

[35]  M. Prince,et al.  World Alzheimer Report 2015 - The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends , 2015 .

[36]  S. I. Rubinow,et al.  Introduction to Mathematical Biology , 1975 .

[37]  L. Mucke,et al.  Alzheimer's disease: A prion protein connection , 2009, Nature.

[38]  P. Olver.  Nonlinear Systems , 2013 .

[39]  Laurent Pujo-Menjouet,et al.  Analysis of a model for the dynamics of prions , 2005 .

[40]  Steven A. Orszag,et al.  CBMS-NSF REGIONAL CONFERENCE SERIES IN APPLIED MATHEMATICS , 1978 .

[41]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[42]  Christoph Walker,et al.  On the solvability of a mathematical model for prion proliferation , 2006 .

[43]  Lawrence M. Wein,et al.  The Impact of Novel Treatments on A\03B2 Burden in Alzheimer's Disease: Insights From a Mathematical Model , 2015 .

[44]  S. Strittmatter,et al.  Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an alzheimer's disease model mouse , 2010, BMC Neuroscience.

[45]  Björn Granseth,et al.  Spreading of Neurodegenerative Pathology via Neuron-to-Neuron Transmission of β-Amyloid , 2012, The Journal of Neuroscience.

[46]  MEREDITH L. GREER,et al.  Effects of General Incidence and Polymer Joining on Nucleated Polymerization in a Model of Prion Proliferation , 2007, SIAM J. Appl. Math..

[47]  D. Kirschner,et al.  On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Seth Love,et al.  Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial , 2008, The Lancet.

[49]  Eng-Hui Yap,et al.  Determining the critical nucleus and mechanism of fibril elongation of the Alzheimer's Abeta(1-40) peptide. , 2007, Journal of molecular biology.

[50]  Marie Doumic,et al.  A Structured Population Model of Cell Differentiation , 2010, SIAM J. Appl. Math..